3,4-dihydroxyphenylethanol has been researched along with Parkinson Disease, Secondary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, R; Pathania, A; Sandhir, R | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylethanol and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson's disease model.
Topics: Animals; Antiparkinson Agents; Blood Platelets; Computer Simulation; Dopamine; Dopaminergic Neurons; Humans; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Dynamics Simulation; Monoamine Oxidase; MPTP Poisoning; Neostriatum; Olive Oil; Parkinson Disease, Secondary; Phenylethyl Alcohol; Substantia Nigra | 2021 |